CA
NZ
UK
AU
IND
US
Biogen disclosed its second quarter 2026 financial results and operational updates in a regulatory filing dated July 29, 2026. The disclosure covers revenue performance across multiple therapeutic programs, integration activities related to the Apellis Pharmaceuticals acquisition, and pipeline developments including milestone payments tied to …
Garmin Ltd. disclosed its second-quarter 2026 financial performance and provided updates to its capital allocation strategy in a quarterly report filed on July 29, 2026. The disclosure includes operational metrics across multiple business segments, balance sheet information, and details regarding the company's ongoing share …
Masco Corporation disclosed its second quarter 2026 financial results on July 29, 2026, through a press release filed with the Securities and Exchange Commission. The building products and home improvement company announced earnings alongside supplemental information intended for investor analysis. The disclosure marks the …
Masco Corporation disclosed its second quarter 2026 financial results in a regulatory filing dated July 29, 2026. The company operates through two primary business segments: Plumbing Products and Decorative Architectural Products, serving customers in North America and international markets. The filing provides investors with …
GTX disclosed its second quarter 2026 financial and operational results in a periodic report filed with the SEC on July 29, 2026. The filing provides detailed financial position and performance metrics for the period ending June 30, 2026, alongside comparative data from prior periods. …
Hayward Holdings, Inc. disclosed its financial results for the three months ended June 27, 2026, through a press release announcement filed with the Securities and Exchange Commission on July 29, 2026. The disclosure marks the company's quarterly earnings update and provides investors with insight …
Hayward Holdings Inc. disclosed its second quarter 2026 financial results on July 29, 2026, providing investors with updated performance metrics across its residential pool, commercial pool, and flow control segments. The company operates through geographically diverse markets including the United States, Canada, Europe, and …
UniQure N.V., the gene therapy company trading on NASDAQ, has restructured its segment operating expense reporting framework for 2026, introducing more granular financial disclosure practices. The company separated information technology system costs as a distinct line item and reclassified consumables within other segment items …
uniQure N.V., a gene therapy company trading on the Nasdaq Global Select Market, announced its financial results for the quarter ended June 30, 2026, on July 29, 2026. The announcement included a corporate update alongside the quarterly earnings report. The disclosure provides investors with …
Verisk Analytics, Inc. disclosed its financial performance for the quarter ended June 30, 2026, through a press release issued on July 29, 2026. The announcement provided investors with operational and financial metrics for the second quarter of the fiscal year. The disclosure marks a …
Please wait processing your request...